Hear from Axol experts on the exciting potential of human iPSCs in building advanced disease models and enabling patient stratification for research and drug discovery.

On Wednesday 26th July (4pm BST), we’ll be running a webinar on “Using the power of iPSCs for patient stratification” hosted by our Chief Scientific Officer, Ashley Barnes, and our Head of Sales and Marketing, Duncan Borthwick.

You can expect Ashley and Duncan to cover:

• The value of iPSC-based cell models in capturing population diversity
• Overcoming the current limitations of in vitro disease models
• The importance of quality and consistency of iPSC disease models, including the current regulatory landscape
• Utilizing high-throughput cell assays for drug discovery
• How patient stratification can de-risk and accelerate drug discovery, including identifying key biomarkers that predict drug efficacy

Axol Webinar |Wed, July 26, 4:00 PM – 5:00 PM (BST) | 4pm BST | 5pm CEST | 10am CDT | 11am EDT | 8am PDT | 

Want to learn more? Visit our patient stratification page here.